Clough Capital Partners L P Takes $842,000 Position in Oscar Health, Inc. $OSCR

Clough Capital Partners L P acquired a new position in Oscar Health, Inc. (NYSE:OSCR) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 44,454 shares of the company’s stock, valued at approximately $842,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. bought a new position in Oscar Health during the 1st quarter valued at about $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Oscar Health by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock valued at $2,827,000 after acquiring an additional 8,879 shares during the last quarter. Jones Financial Companies Lllp grew its stake in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Oscar Health by 39.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock valued at $6,169,000 after purchasing an additional 132,149 shares during the last quarter. 75.70% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Mario Schlosser sold 23,038 shares of the firm’s stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total transaction of $406,620.70. Following the sale, the insider directly owned 350,180 shares in the company, valued at $6,180,677. This trade represents a 6.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold 138,835 shares of company stock valued at $2,298,269 over the last three months. Corporate insiders own 24.39% of the company’s stock.

Oscar Health Stock Up 1.7%

OSCR stock opened at $13.22 on Friday. The business’s 50-day moving average price is $14.53 and its 200-day moving average price is $16.47. The stock has a market cap of $3.93 billion, a P/E ratio of -7.59 and a beta of 1.91. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.80. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.44.

Oscar Health (NYSE:OSCR) last released its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The firm had revenue of $2.81 billion during the quarter, compared to analysts’ expectations of $3.12 billion. During the same period in the prior year, the company posted ($0.62) earnings per share. The company’s revenue was up 17.3% compared to the same quarter last year. On average, equities research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on OSCR. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research report on Thursday, February 12th. Barclays set a $18.00 target price on Oscar Health and gave the stock an “equal weight” rating in a research report on Monday, January 5th. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. UBS Group reaffirmed a “neutral” rating and set a $15.00 target price on shares of Oscar Health in a report on Wednesday, February 11th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a research report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $16.88.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.